Organization · Community
Atlanpole Biotherapies
Atlanpole Biotherapies is an interregional competitiveness cluster in France that promotes innovation and collaboration in life sciences and healthcare, focusing on biotherapies, medical technologies, and digital health solutions.
Overview
What Atlanpole Biotherapies does
What Atlanpole Biotherapies is
Atlanpole Biotherapies is an interregional competitiveness cluster in France that promotes innovation and collaboration in life sciences and healthcare, focusing on biotherapies, medical technologies, and digital health solutions.
How it participates in the startup ecosystem
The current public profile supports community capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Community
- Structured capabilities
- Community
- Last reviewed
- April 28, 2026
Official channels
Find Atlanpole Biotherapies elsewhere
Open the official website or a supported primary organization account.
Capability profile
Atlanpole Biotherapies as a community
Community overview
Atlanpole Biotherapies is an interregional competitiveness cluster based in the Pays de la Loire, Bretagne, and Centre Val de Loire regions of France. Established in July 2005 and recognized by the Ministry of Industry, the organization focuses on supporting entrepreneurs, researchers, clinicians, and pharmaceutical industries in developing new collaborations and enhancing business opportunities.
Community focus
Atlanpole Biotherapies invests in and provides services related to biotherapies, bioproduction, pharma, innovative medical technologies, digital health, and disease prevention. The organization aims to support innovation and business development in these areas.
Member value
Members of Atlanpole Biotherapies benefit from networking opportunities, collaboration with industry leaders, and access to resources that enhance their business development efforts.
Membership
- Pricing models
- free
Format and cadence
- Modality
- in-person
- Schedule
- rolling-admissions
- Commitment
- light
Availability
- Membership state
- Accepting
- Next recorded event
- April 28, 2026
Audience and fit
- Audience
- Founders · Researchers · Operators
- Benefits
- network-access and mentorship
- Program types
- community
- Selection criteria
- open
- Sectors
- Biotech & Life Sciences
Community activity
- Annual events
- 5
Events and activity
Atlanpole Biotherapies organizes several events, including Techno Conférence: la Santé à l’ère du numérique (April 28, 2026), Tour de France de l’Innovation en Santé | Étape Bretagne (May 28, 2026), Journée Nationale de la Bioproduction de Biomédicaments 2026 – Nantes (June 4, 2026), Start-up innovantes du dispositif médical (June 9, 2026), and Séminaire Session d’étude SFSTP: Validation des Bio-essais (June 18, 2026).
Notable members
Notable members of the Atlanpole Biotherapies network include Goliver Therapeutics, Abcely, Caen Normandie Développement, Ceva Biovac, Aqualeg, Clairmont Novus Avocats, Procope Medicals, Biotrial Pharmacology, Parean Biotechnologies, CXS Therapeutics, Gliocure, and Read Pharma Development.
Common questions
What to know about Atlanpole Biotherapies
Upseed classifies Atlanpole Biotherapies under the Community organization type. Its current public profile includes community capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.